Immune health was an important and growing concern even before the 2020 pandemic, and it is now inconceivable that the importance of immunity support could diminish in any short term. Read about key natural ingredients highlighted by Layn USA Chief Scientific Advisor, Jim Roza, including CBD, in addition to a full suite of complementary botanicals that show evidence in supporting the immune system from our parent company Layn Natural Ingredients: 🌱Cistanche 🌱Pu’er Tea 🌱Broccoli Seed 🌱Honeysuckle 🌱Quercetin
“According to Nielsen, the hempderived CBD market is booming, and is expected to reach $2.3 billion this year and climb to $6 billion by 2025,” observes Collette Kakuk, vice president of global marketing, HempRise, a subsidiary of Layn Natural Ingredients.
Grain-based foods companies interested in the expanding hemp market should take heed. Seeds and CBD (cannabidiol) are two parts of the plant that may present marketing opportunities, but flavor issues need addressing.
Hemp is a booming industry, but challenges exist all along the supply chain—from farmers’ inexperience to processing details to meeting consumer demand.
Layn Corp. has registered its hemp-derived CBD business based in Indiana as HempRise LLC, which will operate as a wholly-owned subsidiary of the global botanical extracts and plant-based ingredients company.
NEWPORT BEACH, CALIF. — Layn Corp., a global company involved in the vertically integrated production of plant-based sweeteners and extracts, has set up four business units, including Plantae, its new functional botanicals unit. The other three units are plant-based sweeteners, cannabidiol (C.B.D.) and other hemp extracts, and animal nutrition.
The company has an advantage over other C.B.D. suppliers in that Layn USA already has experience in the food industry, she said. The company for more than 20 years has taken extractions from stevia and monk fruit to use as sweeteners.
Layn Corp – best known for its stevia, monk fruit, and botanical ingredients - is making a significant bet on hemp-derived CBD, announcing plans to invest around $60m to build a US facility capable of processing a minimum of 5,000 tons of hemp biomass per year into full- and broad-spectrum oil, distillate and crystallized CBD isolate.